These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26597434)

  • 1. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
    Conrad MA; Cui J; Lin HC
    J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?
    Etogo-Asse F; Boemer F; Sempoux C; Geubel A
    Acta Gastroenterol Belg; 2008; 71(1):36-8. PubMed ID: 18396749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis].
    Yoon JY; Min SY; Park JY; Hong SG; Park SJ; Paik SY; Park YM
    Korean J Hepatol; 2008 Mar; 14(1):97-101. PubMed ID: 18367862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute cholestatic hepatitis probably caused by sertraline].
    Galán Navarro JL
    Rev Esp Enferm Dig; 2001 Dec; 93(12):822. PubMed ID: 11995366
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
    Tejedor-Tejada J; García-Pajares F; Madrigal Rubiales B
    J Gastroenterol Hepatol; 2019 Mar; 34(3):488. PubMed ID: 30536927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.
    Altraif I; Lilly L; Wanless IR; Heathcote J
    Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
    Davies MH; Harrison RF; Elias E; Hübscher SG
    J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing bile duct syndrome temporally associated with ibuprofen use.
    Alam I; Ferrell LD; Bass NM
    Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
    Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
    Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
    Rahier JF; Rahier J; Leclercq I; Geubel AP
    Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsyndromic paucity of intrahepatic bile ducts in infancy and idiopathic ductopenia in adulthood: the same syndrome?
    Bruguera M; Llach J; Rodés J
    Hepatology; 1992 May; 15(5):830-4. PubMed ID: 1568724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
    Levine C; Trivedi A; Thung SN; Perumalswami PV
    Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
    Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
    Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics.
    Bessone F; Hernández N; Tanno M; Roma MG
    Semin Liver Dis; 2021 Aug; 41(3):331-348. PubMed ID: 34130334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced bile duct injury: progress and challenges].
    Li DL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.